APHP on OTC
American Picture House Corp
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with Nomadar Corp., ACRO BIOMEDICAL CO., LTD. or Fast Track Group, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs100¢$853.0K
Out of $853.0K in revenue.3 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenues | $853.0K | $52.7K |
| Gross profit | $853.0K | $52.7K |
| General and administrative | $1.4M | $2.3M |
| Research and development | $703 | |
| Sales and marketing | $10.6K | $25.9K |
| Total Operating Expenses | $1.4M | $2.3M |
| Net Operating Loss | -$560.6K | -$2.2M |
| Interest income | $97.0K | $2.0K |
| Interest expense | -$70.9K | -$46.1K |
| Net Other Income (Expenses) | $26.1K | -$44.2K |
| Loss before income taxes | -$534.4K | -$2.3M |
| Net loss | -$534.4K | -$2.3M |
| Net loss per common share - Basic | $0.00 | -$0.02 |
| Net loss per common share - Diluted | $0.00 | -$0.02 |
| Weighted average shares used in per share computation - Basic | 112.7M shares | 111.1M shares |
| Weighted average shares used in per share computation - Diluted | 112.7M shares | 111.1M shares |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2025-09-30 | 2024-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $124 | ||
| Accounts receivable | $1.1M | $29.7K | |
| Prepaid expenses | $28.4K | $29.6K | |
| Total Current Assets | $1.2M | $63.4K | |
| Produced and licensed content costs | $300.0K | $300.0K | $638.1K |
| Loans receivable, film financing arrangements | $396.2K | ||
| Intangible assets, net of accumulated amortization of $42,583 and $19,250 as of December 31, 2025 and 2024, respectively. | $27.4K | $75.6K | |
| TOTAL ASSETS | $1.5M | $1.2M | |
| Cash overdraft | $21 | ||
| Accounts payable and accrued expenses | $655.2K | $510.0K | |
| Deferred revenue, current portion | $50.0K | $50.0K | |
| Interest payable - related party | $42.2K | $12.4K | |
| Interest payable - EIDL loan | $6.1K | $13.1K | |
| Commercial Line of Credit | $97.9K | $96.9K | |
| Total Current Liabilities | $1.6M | $1.0M | |
| Economic injury disaster loan, non-current | $149.9K | $149.9K | |
| Total Liabilities | $1.8M | $1.2M | |
| Common Stock $0.0001 par value. 1,000,000,000 authorized. 113,399,325 and 112,399,325 issued and outstanding as of December 31, 2025 and 2024, respectively. | $11.3K | $11.2K | |
| Additional paid in capital | $7.6M | $7.3M | |
| Accumulated deficit | -$7.8M | -$7.3M | |
| Total Stockholders Equity (Deficit) | -$257.5K | -$16.7K | |
| TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT) | $1.5M | $1.2M | |
| Intangible assets, accumulated amortization | $42.6K | $19.2K | |
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 1.0B shares | 1.0B shares | |
| Common stock, shares issued | 113.4M shares | 112.4M shares | |
| Common stock, shares outstanding | 113.4M shares | 112.4M shares | |
| Preferred stock, par value | $0.00 | $0.00 | |
| Preferred stock, shares authorized | 1.0M shares | 1.0M shares | |
| Preferred stock, shares issued | 3.8K shares | 3.8K shares | |
| Preferred stock, shares outstanding | 3.8K shares | 3.8K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net Income (Loss) | -$534.4K | -$2.3M |
| Reserve for uncollectible receivable | $196.2K | |
| Expiration of produced and licensed costs | $150.8K | $26.6K |
| Stock option expense | $379.1K | $1.3M |
| Commons stock issued for services | $170.5K | $86.0K |
| Preferred stock redeemed in exchange for assets | -$42.6K | |
| Amortization expense | $23.3K | $18.2K |
| Accounts receivable | -$1.1M | $2.3K |
| Prepaid expenses | $1.3K | -$444 |
| Receivables - related party | $4.1K | -$2.7K |
| Loans receivable, film financing arrangements | $200.0K | -$396.2K |
| Produced and licensed costs | -$1.2K | -$10.8K |
| Cash overdraft | -$21 | $21 |
| Accounts payable and accrued expenses | $145.1K | $419.7K |
| Interest payable - related parties | $29.8K | $12.4K |
| Interest payable - EIDL loan | -$7.1K | $1.6K |
| Deferred revenue | $50.0K | |
| Net Cash Flows from Operating Activities | -$405.5K | -$805.4K |
| Intangible assets | -$22.0K | |
| Net Cash Flows from Investing Activities | -$22.0K | |
| Proceeds from issuance of note payable | $115.0K | |
| Proceeds from debt borrowings - related parties | $381.8K | $387.9K |
| Repayment of debt borrowings - related parties | -$92.2K | -$30.3K |
| Proceeds from commercial line of credit | $1.1K | $142.6K |
| Repayments on commercial line of credit | -$45.7K | |
| Proceeds from sale of Common Stock | $169.0K | |
| Net Cash Flows from Financing Activities | $405.6K | $623.5K |
| Net Increase in Cash and Cash Equivalents | $124 | -$204.0K |
| Common Stock issued for services | $170.5K | $86.0K |
Recent filings
- Aug 14, 202610-Q
- Aug 12, 20264
- Aug 12, 20264
- May 14, 202610-Q
- Mar 30, 202610-K
- Mar 20, 20268-K
- Mar 18, 20268-K
- Mar 18, 20268-K
- Mar 16, 20264
- Jan 8, 20264
- Nov 6, 202510-Q
- Sep 19, 20258-K/A
- Sep 19, 20258-K
- Sep 19, 20258-K
- Sep 3, 20258-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7